MEDICAL INFORMATION

Home

Call the toll-free number below to request specific product information or report adverse events of COMPLERA (emtricitabine 200 mg/ rilpivirine 25 mg/ tenofovir disoproxil fumarate 300 mg) tablets.

Tap for IMPORTANT SAFETY INFORMATION, including BOXED WARNING on lactic acidosis, severe hepatomegaly with steatosis, and post treatment acute exacerbation of hepatitis B.

By following this link, you are now leaving www.complera.com. This site is not controlled by Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for the content or your use of it.

Leave site Go back

By following this link, you are now
leaving m.complerahcp.com. This
site is not controlled by Gilead
Sciences, Inc. Gilead Sciences, Inc.
is not responsible for the content or
your use of it.


Go back